Global Prasugrel Hydrochloride Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prasugrel Hydrochloride Market Research Report 2024
Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing activation of the GPIIb/IIIa receptor complex. As a result, inhibition of ADP-mediated platelet activation and aggregation occurs. Prasugrel was developed by Daiichi Sankyo Co. and is currently marketed in the United States and Canada in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). FDA approved in 2009.
According to Mr Accuracy reports’s new survey, global Prasugrel Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prasugrel Hydrochloride market research.
Key manufacturers engaged in the Prasugrel Hydrochloride industry include Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Prasugrel Hydrochloride were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Prasugrel Hydrochloride market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prasugrel Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Daiichi Sankyo
Amneal Pharmaceuticals
Apotex
Ube
Ascend Laboratories
Liberty Pharmaceuticals
Panacea Biotec
Segment by Type
5mg
10mg
Hospital
Drugs Store
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Prasugrel Hydrochloride report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Prasugrel Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prasugrel Hydrochloride market research.
Key manufacturers engaged in the Prasugrel Hydrochloride industry include Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Prasugrel Hydrochloride were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Prasugrel Hydrochloride market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prasugrel Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Daiichi Sankyo
Amneal Pharmaceuticals
Apotex
Ube
Ascend Laboratories
Liberty Pharmaceuticals
Panacea Biotec
Segment by Type
5mg
10mg
Segment by Application
Hospital
Drugs Store
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Prasugrel Hydrochloride report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices